Treatment for Skull Biopsy Site Infection Resembling Impetigo

Initial Assessment and Management

For a skull biopsy site infection with impetigo-like features, treat with oral antibiotics active against Staphylococcus aureus for 7 days, using dicloxacillin or cephalexin as first-line agents, or clindamycin, doxycycline, or trimethoprim-sulfamethoxazole if MRSA is suspected, as recommended by the Infectious Diseases Society of America 1, 2
Obtain Gram stain and culture from the wound site before initiating treatment, as this is a surgical site infection requiring microbiologic confirmation, according to the Clinical Infectious Diseases guidelines 1, 2
Assess for systemic signs: fever, tachycardia, elevated white blood cell count, or extent of erythema from the incision, as suggested by the Clinical Infectious Diseases guidelines 1, 2

First-line oral antibiotics (7-day course) include dicloxacillin or cephalexin if methicillin-susceptible S. aureus (MSSA) is expected, as recommended by the Infectious Diseases Society of America 1, 2
If MRSA is suspected or confirmed, switch to MRSA-active oral agents, such as clindamycin, trimethoprim-sulfamethoxazole, or doxycycline, as suggested by the Clinical Infectious Diseases guidelines 1, 2, 4
For systemic signs or failed oral therapy, initiate IV antibiotics, such as vancomycin or cefazolin, and continue for 7-14 days based on clinical response, according to the Clinical Infectious Diseases guidelines 1, 2, 4

This is a surgical site infection, not simple impetigo, requiring more aggressive management, as stated by the Clinical Infectious Diseases guidelines 1, 2
Open and debride if purulent drainage is present or if there is necrosis, as recommended by the Infectious Diseases Society of America 1, 2
The skull location increases risk of deeper infection; monitor closely for signs of osteomyelitis or intracranial extension, as suggested by the Clinical Infectious Diseases guidelines 1

Do not use topical antibiotics alone for a surgical site infection, even if it resembles impetigo - systemic therapy is required, as stated by the Clinical Infectious Diseases guidelines 1, 2
Do not add rifampin as adjunctive therapy - it is not recommended for skin and soft tissue infections, according to the Clinical Infectious Diseases guidelines 4
Avoid trimethoprim-sulfamethoxazole monotherapy unless streptococcal infection is definitively ruled out by culture, as suggested by the Clinical Infectious Diseases guidelines 4

Complete the full 7-day course even if symptoms improve quickly, as recommended by the Infectious Diseases Society of America 1, 2
Reassess at 48-72 hours: if no improvement, consider MRSA coverage or alternative diagnosis, as suggested by the Clinical Infectious Diseases guidelines 1, 4
Culture results should guide definitive antibiotic selection and potential de-escalation, according to the Clinical Infectious Diseases guidelines 1, 2